Women’s Health

Tadalafil May Ease Voiding Problems in Women

In a small study, tadalafil, a PDE5 inhibitor used to treated erectile dysfunction, significantly decreased opening urethral pressure in healthy women.

Fezolinetant NDA Accepted for Vasomotor Symptoms Associated With Menopause

Fezolinetant is an investigational, nonhormonal selective neurokinin-3 receptor antagonist.

Mirena Approved for Pregnancy Prevention for Up to 8 Years

By the end of the 8th year, Mirena should be removed and replaced at the time of removal with a new system if continued use is desired.

Does Endometriosis Up Risk for Stroke in Women Later in Life?

Researchers sought to investigate the association between women with laparoscopically confirmed endometriosis and the risk for stroke.

Chewing Xylitol Gum Can Promote Earlier Bowel Function After Cesarean Delivery

Researchers examined the effects of xylitol gum chewing on bowel functions after a patient’s cesarean delivery.

FDA Approves Haloette Vaginal Hormonal Contraceptive Ring

Haloette is an estrogen/progestin combination hormonal contraceptive.

Ibrexafungerp Under Review for Prevention of Recurrent Vulvovaginal Candidiasis

The sNDA is supported by data from the phase 3 CANDLE study.

PENS Device Cleared To Treat Pain Following C-Section Delivery

Approval was based on a prospective study that included 44 participants who underwent C-section delivery.

Rx-to-OTC Switch Application Submitted for Oral Contraceptive Opill

If approved, Opill would be the first OTC birth control pill available without a prescription.

Presidential Advisory From the AHA: Call to Action for Cardiovascular Disease in Women

The AHA has issued a presidential advisory statement regarding sex-based disparities in care of patients with cardiovascular disease.

In Women, Hormones and Gender Affect Asthma Incidence and Treatment Response

Recent research shows that in women, hormonal and other changes occurring during their lifecycle affect their asthma incidence and response to treatment.

Post Hoc Analysis Shows Phexxi Prevented 99% of Pregnancies Per Act of Intercourse

Phexxi is a nonhormonal, on-demand contraceptive designed to regulate vaginal pH in the range of 3.5 to 4.5, maintaining an acidic environment that is inhospitable to sperm.

Doxycycline vs Azithromycin as First-line Treatment for Women With Chlamydia

Researchers compared the efficacy of doxycycline with azithromycin among women with anorectal Chlamydia trachomatis infection.

FDA to Review Data on Long-Term Use of Myfembree for Uterine Fibroids

The study enrolled women who completed the 24-week LIBERTY 1 and 2 studies and the 28-week open-label extension studies, and who met the definition of a responder.

FDA Extends Shelf Life of On-Demand Contraceptive Phexxi

Phexxi is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

Trial Evaluating Zuranolone for Postpartum Depression Meets All Endpoints

Zuranolone is an investigational oral neuroactive steroid GABA-A receptor positive allosteric modulator.

How Will Abortion Bans Affect Women’s Health?

Medical experts discuss the clinical implications of the potential overturn of Roe v Wade for women’s health.

Annovera Product Supply Expected to Increase Following FDA Approval

According to the Company, these revisions will significantly reduce manufacturing batch rejections and increase future product supply.

Anxiety and Depression: Understanding the Risk for Preeclampsia

Rates of anxiety and depression have increased during the pandemic and are linked to preeclampsia risk, making screening for mental health conditions at prenatal visits essential.

Pregnancy With Cirrhosis Increased in US, Linked to Maternal and Perinatal Outcomes

Researchers compared maternal and perinatal outcomes in US pregnant patients with cirrhosis, noncirrhotic chronic liver disease (CLD), and without CLD.